TMVR boosts survival, cuts hospitalization in HF patients
Transcatheter mitral valve repair (TMVR) is safe, provides a durable reduction in mitral regurgitation (MR), reduces rate of heart failure (HF) hospitalization, and improves survival, quality of life, and functional capacity in patients with HF and moderate-to-severe or severe MR who remained symptomatic despite guideline-directed medical therapy (GDMT), a study has shown.